Anzeige
Mehr »
Montag, 16.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
351 Leser
Artikel bewerten:
(2)

Decimal.health Appoints Diana Gelston as President and Managing Partner to Lead the Company's Next Phase of Growth

BOSTON, MA / ACCESS Newswire / October 16, 2025 / Decimal.health today announced the appointment of Diana Gelston as President and Managing Partner, a key milestone in the company's evolution. Diana joins Decimal at a pivotal moment as the firm expands its impact across three powerful growth engines: Decimal.health, its strategy consulting and commercialization business; Ecosystem Development, like CancerX - the national collaborative advancing innovation in oncology; and AccelerOnc Studio, the venture focused on building, scaling, and investing in breakthrough oncology innovation.

"Decimal has reached an exciting stage in its growth," said Kamal Jethwani, MD, Chief Executive Officer of Decimal.health. "As we continue to expand across our three core businesses, we need a strong and proven leader to help guide the organization into its next chapter. Bringing Diana on board is a tremendous win. She's a proven voice in the industry, known for her strategic clarity, commercial rigor, and people-first leadership that will accelerate our growth and amplify our impact across healthcare."

Diana brings over 30 years of experience driving transformation and growth across healthcare, digital health, and technology. She has held senior leadership roles at Best Buy Health, Amazon Business Healthcare, Fresenius Medical Care, Philips Healthcare, and several innovative start-ups, managing over $2B in P&L and $5B in business transformations. Throughout her career, she has built and led high-performing teams that deliver commercial excellence, inspire innovation, and create meaningful impact for patients, partners, and communities.

"I am honored to join Decimal at such an extraordinary moment," said Diana Gelston. "This company stands at the intersection of innovation and impact, uniting commercialization expertise, ecosystem collaboration, strategy and real-world change. I am inspired by what has been built and excited to work with the team to scale our reach, grow our partnerships, and turn potential into lasting results."

As President and Managing Partner, Diana will lead strategy, operations, and growth across Decimal.health and Ecosystem development initiatives, partnering closely with Kamal Jethwani, who continues as CEO of Decimal.health, with a focus on driving growth for AccelerOnc Studio and broader innovation initiatives.

Together, we're building a holistic platform for digital health innovation that spans the entire journey - from concept to scale:

  • Decimal.health continues to lead in digital health strategy, design, and product acceleration.

  • AccelerOnc Studio, our new venture studio built in partnership with Moffitt Cancer Center, brings venture-building capabilities to help invent, fund, and pilot breakthrough oncology solutions.

  • Ecosystem Design builds cross-industry ecosystem connections that help those solutions scale, like CancerX that does this across the cancer care continuum.

This integrated approach allows us to offer our clients something truly unique - a unified pathway to invent, validate, and scale digital health solutions that make a lasting impact.

About Decimal.health

Decimal.health is a digital health innovation firm that provides strategy consulting, venture building, thought leadership, and community development to help health systems, life sciences companies, and digital health innovators bring evidence based solutions to market. As the venture-building force behind AccelerOnc Studio, and the operational backbone of CancerX, we power some of the most transformative programs in healthcare. www.decimal.health

Media Contact

Vrushali Malpekar
Director of Marketing, Decimal.health
vrushali@decimal.health
(408) 645-4286

SOURCE: Decimal.health



View the original press release on ACCESS Newswire:
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/decimal.health-appoints-diana-gelston-as-president-and-managing-partn-1087348

© 2025 ACCESS Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.